Karo Pharma Aktiebolag has applied for its shares to be delisted from Nasdaq Stockholm. Conditional on that the shares are admitted to trading on Nasdaq First North Growth Market, Nasdaq Stockholm AB has approved the application and decided to delist the shares in Karo Pharma Aktiebolag. Short name: KARO ---------------------------- ISIN code: SE0007464888 ---------------------------- Order book ID: 003927 ---------------------------- Provided that the shares have been admitted to trading on Nasdaq First North Growth Market, the last day of trading on Nasdaq Stockholm will be March 24, 2022. For further information regarding this exchange notice please contact Enforcement & Investigations, telephone + 46 8 405 60 00.
© 2022 GlobeNewswire
